Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2010 2
2012 3
2013 3
2014 8
2015 4
2016 7
2017 8
2018 2
2019 6
2020 6
2021 11
2022 14
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Liver inflammation and fibrosis.
Koyama Y, Brenner DA. Koyama Y, et al. J Clin Invest. 2017 Jan 3;127(1):55-64. doi: 10.1172/JCI88881. Epub 2017 Jan 3. J Clin Invest. 2017. PMID: 28045404 Free PMC article. Review.
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY, Yamamoto G, Xu J, Liu X, Karin D, Kim JY, Alexandrov LB, Koyama Y, Nishio T, Benner C, Heinz S, Rosenthal SB, Liang S, Sun M, Karin G, Zhao P, Brodt P, Mckillop IH, Quehenberger O, Dennis E, Saltiel A, Tsukamoto H, Gao B, Karin M, Brenner DA, Kisseleva T. Ma HY, et al. Among authors: koyama y. J Hepatol. 2020 May;72(5):946-959. doi: 10.1016/j.jhep.2019.12.016. Epub 2019 Dec 31. J Hepatol. 2020. PMID: 31899206 Free PMC article.
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
Liu X, Xu J, Rosenthal S, Zhang LJ, McCubbin R, Meshgin N, Shang L, Koyama Y, Ma HY, Sharma S, Heinz S, Glass CK, Benner C, Brenner DA, Kisseleva T. Liu X, et al. Among authors: koyama y. Gastroenterology. 2020 May;158(6):1728-1744.e14. doi: 10.1053/j.gastro.2020.01.027. Epub 2020 Jan 23. Gastroenterology. 2020. PMID: 31982409 Free PMC article.
New therapies for hepatic fibrosis.
Koyama Y, Brenner DA. Koyama Y, et al. Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1(0 1):S75-9. doi: 10.1016/j.clinre.2015.06.011. Epub 2015 Jul 20. Clin Res Hepatol Gastroenterol. 2015. PMID: 26206573 Free PMC article. Review.
Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.
Nishio T, Koyama Y, Liu X, Rosenthal SB, Yamamoto G, Fuji H, Baglieri J, Li N, Brenner LN, Iwaisako K, Taura K, Hagood JS, LaRusso NF, Bera TK, Pastan I, Brenner DA, Kisseleva T. Nishio T, et al. Among authors: koyama y. Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2101270118. doi: 10.1073/pnas.2101270118. Proc Natl Acad Sci U S A. 2021. PMID: 34253615 Free PMC article.
Promising Therapy Candidates for Liver Fibrosis.
Wang P, Koyama Y, Liu X, Xu J, Ma HY, Liang S, Kim IH, Brenner DA, Kisseleva T. Wang P, et al. Among authors: koyama y. Front Physiol. 2016 Feb 16;7:47. doi: 10.3389/fphys.2016.00047. eCollection 2016. Front Physiol. 2016. PMID: 26909046 Free PMC article. Review.
New Developments on the Treatment of Liver Fibrosis.
Koyama Y, Xu J, Liu X, Brenner DA. Koyama Y, et al. Dig Dis. 2016;34(5):589-96. doi: 10.1159/000445269. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332862 Free PMC article. Review.
A Conceptual Classification of Resectability for Hepatocellular Carcinoma.
Yoh T, Ishii T, Nishio T, Koyama Y, Ogiso S, Fukumitsu K, Uchida Y, Ito T, Seo S, Hata K, Hatano E. Yoh T, et al. Among authors: koyama y. World J Surg. 2023 Mar;47(3):740-748. doi: 10.1007/s00268-022-06803-7. Epub 2022 Oct 26. World J Surg. 2023. PMID: 36287266 Free PMC article.
73 results